Literature DB >> 175217

The effects of long chain free fatty acids on human neutrophil function and structure.

H P Hawley, G B Gordon.   

Abstract

Neutrophils from healthy volunteers were isolated and incubated with varying concentrations of albumin-bound long chain free fatty acids. Standard in vitro function tests including phagocytosis, bactericidal activity, and chemotaxis were performed after the incubation. It was found that unsaturated fatty acid (oleic acid) caused no changes in bactericidal activity and only moderate decreases in phagocytosis and chemotaxis at very high concentrations. Saturated fatty acid (palmitic acid) produced, at high concentrations, virtually complete inhibition of chemotaxis and moderate depression of phagocytosis and bactericidal ability. Most significantly, lower concentrations of saturated free fatty acids, within the range reported clinically in various diseases, caused a marked inhibition of chemotaxis. These functional disturbances were associated with ultrastructural alterations. Neutrophils treated with oleic acid contained numerous cytoplasmic neutral lipid droplets. Neutrophils incubated with palmitic acid showed elongated cleftlike dilations of the endoplasmic reticulum and degenerative degranulated cytoplasmic areas. It is postulated that these represent crystallization of excess saturated free fatty acids or triglyceride which interfere with chemotaxis, either mechanically or by causing cell injury.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175217

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  In vivo processing of Staphylococcus aureus lipase.

Authors:  J Rollof; S Normark
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

2.  Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.

Authors:  T Wasada; B Howard; R E Dobbs; R H Unger
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

3.  Development of a recombinant protein-based enzyme-linked immunosorbent assay for diagnosis of Mycoplasma bovis infection in cattle.

Authors:  Nadeeka K Wawegama; Glenn F Browning; Anna Kanci; Marc S Marenda; Philip F Markham
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

4.  Intralipid alters macrophage membrane fatty acid composition and inhibits complement (C2) synthesis.

Authors:  R C Strunk; K S Kunke; G B Kolski; B K Revsin
Journal:  Lipids       Date:  1983-07       Impact factor: 1.880

5.  Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study.

Authors:  D P Cistola; D M Small
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Cytoplasmic lipid bodies of human neutrophilic leukocytes.

Authors:  P F Weller; S J Ackerman; A Nicholson-Weller; A M Dvorak
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

7.  Chlorinated lipid species in activated human neutrophils: lipid metabolites of 2-chlorohexadecanal.

Authors:  Dhanalakshmi S Anbukumar; Laurie P Shornick; Carolyn J Albert; Melissa M Steward; Raphael A Zoeller; William L Neumann; David A Ford
Journal:  J Lipid Res       Date:  2009-12-17       Impact factor: 5.922

8.  Neuronal lipidosis and neuroaxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome.

Authors:  J M Powers; R C Tummons; A B Moser; H W Moser; D S Huff; R I Kelley
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Mycoplasma hyopneumoniae p65 surface lipoprotein is a lipolytic enzyme with a preference for shorter-chain fatty acids.

Authors:  Jono A Schmidt; Glenn F Browning; Philip F Markham
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

10.  Purification, gene cloning, amino acid sequence analysis, and expression of an extracellular lipase from an Aeromonas hydrophila human isolate.

Authors:  J Anguita; L B Rodríguez Aparicio; G Naharro
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.